Lorazepam for Six Months is Not Safe for Anxiety Treatment
Lorazepam should not be used continuously for six months to treat anxiety—the FDA explicitly states that effectiveness beyond 4 months has not been established, and guidelines consistently warn against prolonged benzodiazepine use due to risks of tolerance, addiction, cognitive impairment, and severe withdrawal reactions. 1
Why Six Months is Too Long
The FDA drug label for lorazepam is unequivocal: "The effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies." 1 This means there is no evidence supporting safety or efficacy beyond this timeframe, and you would be prescribing outside established parameters.
Critical Safety Concerns with Prolonged Use
Dependence and Withdrawal: Regular benzodiazepine use leads to tolerance, addiction, depression, and cognitive impairment 2. The FDA warns that lorazepam causes physical dependence, and abrupt discontinuation can trigger life-threatening withdrawal reactions including seizures, delirium, severe mental status changes, and suicidal ideation 1. Some patients develop protracted withdrawal syndrome lasting weeks to over 12 months 1.
Cognitive Impairment: Guidelines specifically caution that regular benzodiazepine use causes cognitive impairment 2, which worsens with duration of use. In elderly patients, this risk is particularly pronounced 2.
Paradoxical Effects: Approximately 10% of patients experience paradoxical agitation with benzodiazepines 2, and the drug can itself cause delirium 3.
What the Evidence Shows About Duration
Research demonstrates that rebound anxiety occurs after discontinuation, appearing more intense and earlier with short-acting benzodiazepines like lorazepam compared to longer-acting agents 4. One study found that withdrawal sleep disturbance was "several times the peak degree of sleep improvement with drug administration" 5, highlighting that the harm of stopping may exceed the benefit of using.
The 2019 UK national database study found that among patients prescribed benzodiazepines, 32% had been on them continuously for at least 3 years 6, demonstrating how easily short-term prescriptions become long-term dependencies in real-world practice.
Recommended Approach for Anxiety Treatment
First-line treatment for anxiety should be SSRIs or SNRIs, not benzodiazepines 7. The WHO guidelines explicitly state: "Neither antidepressants nor benzodiazepines should be used for the initial treatment of individuals with complaints of depressive symptoms in absence of current/prior depressive episode/disorder" 8, but when treating actual anxiety disorders, antidepressants are preferred.
If Benzodiazepines Are Necessary
When benzodiazepines must be used:
- Limit duration to 2-4 weeks maximum 9
- Use "infrequent, low doses of agents with a short half-life" as least problematic 2
- Consider buspirone as a non-benzodiazepine alternative for mild-to-moderate anxiety (though it takes 2-4 weeks to become effective) 2
- Combine with cognitive behavioral therapy, which increases successful tapering 10
Special Populations at Higher Risk
Elderly patients: More susceptible to sedative effects, cognitive impairment, and falls 3, 11. Initial doses should not exceed 2 mg 1, and recent evidence shows midazolam (a related benzodiazepine) had a 53% adverse event rate in older adults 11.
Patients on opioids: The CDC explicitly warns against concurrent benzodiazepine-opioid use, as it quadruples the risk of overdose death 10. This combination causes potentially fatal respiratory depression 1.
Critical Pitfall to Avoid
The most dangerous pitfall is allowing "temporary" benzodiazepine prescriptions to drift into long-term use. The evidence shows this happens frequently 6, and once physical dependence develops, discontinuation becomes medically complex and potentially dangerous. After 9 months of antidepressant use, dosage reduction should be used to reassess the need to medicate 2—this principle should apply even more stringently to benzodiazepines given their higher risk profile.
If Already on Lorazepam for Extended Period
If a patient is already on lorazepam approaching or exceeding 4 months:
- Do not abruptly discontinue—this can be life-threatening 1
- Taper gradually: a common safe schedule is 25% dose reduction every 1-2 weeks 10
- Consider switching to a longer-acting benzodiazepine before tapering to reduce rebound symptoms 4
- Provide or arrange cognitive behavioral therapy to increase tapering success 10
- Monitor for protracted withdrawal symptoms that may persist for months 1
The answer is clear: six months of continuous lorazepam for anxiety is not supported by evidence, exceeds FDA-established parameters, and exposes patients to serious risks of dependence, cognitive impairment, and dangerous withdrawal reactions.